Of all breast cancer cases, 5–10% have a strong hereditary background and a recent study has estimated the prevalence of pathogenic variants in BRCA1 and BRCA2 among unselected breast cancer patients to be about 4.5% [6]. Here, BRCA2 is linked to breast carcinoma.